Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Biol. Res ; 52: 60, 2019. graf
Article in English | LILACS | ID: biblio-1100912

ABSTRACT

BACKGROUND: Recent studies have confirmed that RASAL1 has an antitumor effect in many cancers, but its functional role and the molecular mechanism underlying in colon cancer has not been investigated. RESULTS: We collected human colon cancer tissues and adjacent non-tumor tissues, human colon cancer cell lines LoVo, CaCo2, SW1116, SW480 and HCT-116, and normal colonic mucosa cell line NCM460. RT-qPCR was used to detect the RASAL1 level in the clinical tissues and cell lines. In LoVo and HCT-116, RASAL1 was artificially overexpressed. Cell viability and proliferation were measured using CCK-8 assays, and cell cycle was detected via PI staining and flow cytometry analysis. RASAL1 significantly inhibited the cell proliferation via inducing cell cycle arrest, suppressed cell cycle associated protein expression, and decreased the lipid content and inhibited the SCD1 expression. Moreover, SCD1 overexpression induced and downregulation repressed cell proliferation by causing cell cycle arrest. Additionally, luciferase reporter assays were performed to confirm the direct binding between SREBP1c, LXRα; and SCD1 promoter, we also demonstrated that RASAL1 inhibit SCD1 3'-UTR activity. RASAL1 inhibited tumor growth in xenograft nude mice models and shows inhibitory effect of SCD1 expression in vivo. CONCLUSION: Taken together, we concluded that RASAL1 inhibited colon cancer cell proliferation via modulating SCD1 activity through LXRα/SREBP1c pathway.


Subject(s)
Humans , Animals , Mice , Stearoyl-CoA Desaturase/metabolism , Colonic Neoplasms/pathology , GTPase-Activating Proteins/metabolism , Cell Proliferation/physiology , Sterol Regulatory Element Binding Protein 1/metabolism , Liver X Receptors/metabolism , Stearoyl-CoA Desaturase/genetics , Down-Regulation , GTPase-Activating Proteins/genetics , Cell Line, Tumor , Sterol Regulatory Element Binding Protein 1/genetics , Liver X Receptors/genetics
2.
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; 39(2): 95-103, Apr.-June 2017. tab
Article in English | LILACS | ID: biblio-844186

ABSTRACT

Objective: To study associations of cerebrovascular metabolism genotypes and haplotypes with age at Alzheimer’s disease dementia (AD) onset and with neuropsychiatric symptoms according to each dementia stage. Methods: Consecutive outpatients with late-onset AD were assessed for age at dementia onset and Neuropsychiatric Inventory scores according to Clinical Dementia Rating scores, apolipoprotein E gene (APOE) haplotypes, angiotensin-converting enzyme gene (ACE) variants rs1800764 and rs4291, low-density lipoprotein cholesterol receptor gene (LDLR) variants rs11669576 and rs5930, cholesteryl ester transfer protein gene (CETP) variants I422V and TaqIB, and liver X receptor beta gene (NR1H2) polymorphism rs2695121. Results: Considering 201 patients, only APOE-ɛ4 carriers had earlier dementia onset in multiple correlations, as well as less apathy, more delusions, and more aberrant motor behavior. Both ACE polymorphisms were associated with less intense frontally mediated behaviors. Regarding LDLR variants, carriers of the A allele of rs11669576 had less anxiety and more aberrant motor behavior, whereas carriers of the A allele of rs5930 had less delusions, less anxiety, more apathy, and more irritability. CETP variants that included G alleles of I422V and TaqIB were mostly associated with less intense frontally mediated behaviors, while severely impaired carriers of the T allele of rs2695121 had more anxiety and more aberrant motor behavior. Conclusion: Though only APOE haplotypes affected AD onset, cerebrovascular metabolism genotypes were associated with differences in several neuropsychiatric manifestations of AD.


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , Cerebrovascular Disorders/genetics , Cerebrovascular Disorders/metabolism , Alzheimer Disease/genetics , Alzheimer Disease/metabolism , Genotype , Apolipoproteins E/genetics , Linear Models , Cerebrovascular Disorders/physiopathology , Cross-Sectional Studies , Age of Onset , Gene Dosage , Alleles , Cholesterol Ester Transfer Proteins/genetics , Genetic Association Studies , Alzheimer Disease/physiopathology , Late Onset Disorders , Liver X Receptors/genetics , Lipoproteins, LDL/genetics , Neuropsychological Tests
SELECTION OF CITATIONS
SEARCH DETAIL